850 PATIENTS WITH MAFLD TAKING GLUCAGON LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT HAVE HIGHER INCIDENCE FOR HEPATOBILIARY CANCER BUT HAVE LOWER OVERALL ...

Sa1451 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS USE DOES NOT INCREASE THE RISK FOR ACUTE PANCREATITIS AND IS ASSOCIATED WITH LOWER COMPLICATIONS IN ...

Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with Glucagon-like peptide-1 receptor agonist use

Measuring the quality and safety of upper endoscopy in patients taking glucagon-like peptide-1 receptor agonists